Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice

被引：19
|
作者：
Litten, Raye Z. [1 ]
Falk, Daniel E. [1 ]
Ryan, Megan L. [1 ]
Fertig, Joanne [1 ]
Leggio, Lorenzo [2 ,3 ,4 ]
机构：
[1] NIAAA, Bethesda, MD USA
[2] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, NIH, Bethesda, MD USA
[3] NIDA, Medicat Dev Program, NIH, Baltimore, MD USA
[4] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2020年 / 44卷 / 01期
关键词：
Medications; Alcohol Use Disorder; Personalized Medicine; Targets; Screening Models; Medication Use; Health Services; Dissemination; PLACEBO-CONTROLLED TRIAL; ADDICTIONS NEUROCLINICAL ASSESSMENT; CELL-BASED MODELS; DOUBLE-BLIND; NALTREXONE RESPONSE; PRIMARY-CARE; DEPENDENT INDIVIDUALS; EXPRESSION SIGNATURES; RECEPTOR ANTAGONIST; PRECISION MEDICINE;
D O I：
10.1111/acer.14233
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：23 / 35
页数：13
相关论文
共 50 条
  • [31] Medications Development for Treatment of Opioid Use Disorder
    Townsend, E. Andrew
    Negus, S. Stevens
    Banks, Matthew L.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2021, 11 (01): : 1 - 26
  • [32] Nociceptin Receptor as a Target to Treat Alcohol Use Disorder: Challenges in Advancing Medications Development
    Litten, Raye Z.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 (11) : 2299 - 2304
  • [33] Use of biomarkers for alcohol use disorders in clinical practice
    Neumann, T
    Spies, C
    ADDICTION, 2003, 98 : 81 - 91
  • [34] Adherence to FDA-Approved Medications for Alcohol Use Disorder
    Blalock, D., V
    Woolson, S.
    Burns, M.
    Bosworth, H. B.
    Dedert, E. A.
    Calhoun, P. S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01)
  • [35] Applying Behavioral Economics to Screen Medications for Alcohol Use Disorder
    Nieto, Steven
    MacKillop, James
    Izquierdo, Alicia
    Ray, Lara
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 463 - 463
  • [36] New glutamatergic target for alcohol and substance use disorder medications
    Csaba Vadasz
    Mariko Saito
    Psychopharmacology, 2014, 231 : 1429 - 1431
  • [37] Medications to Treat Alcohol Use Disorder: Targeting the Dark Side
    Mason, Barbara J.
    AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (05): : 375 - 377
  • [38] Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
    Abraham, Amanda J.
    Andrews, Christina M.
    Harris, Samantha J.
    Friedmann, Peter D.
    NEUROTHERAPEUTICS, 2020, 17 (01) : 55 - 69
  • [39] Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
    Amanda J. Abraham
    Christina M. Andrews
    Samantha J. Harris
    Peter D. Friedmann
    Neurotherapeutics, 2020, 17 : 55 - 69
  • [40] Clinician Prescribing Practices Involving Medications for Alcohol Use Disorder
    Kennedy-Hendricks, Alene
    Busch, Alisa B.
    Azeni, Hocine
    Horgan, Constance M.
    Uscher-Pines, Lori
    Hodgkin, Dominic
    Huskamp, Haiden A.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2025, 68 (03) : 446 - 454
12345